Yale University

Publications

Filters: Keyword is Oligopeptides  [Clear All Filters]
2015
Gordon, Stuart C., Andrew J. Muir, Joseph K. Lim, Brian Pearlman, Curtis K. Argo, Ananthakrishnan Ramani, Benedict Maliakkal, Imtiaz Alam, Thomas G. Stewart, Monika Vainorius et al. "Safety profile of boceprevir and telaprevir in chronic hepatitis C: real world experience from HCV-TARGET." Journal of hepatology 62, no. 2 (2015): 286-93. Abstract
2011
Vergara-Rodriguez, Pamela, Mary Jo Tozzi, Michael Botsko, Vijay Nandi, Frederick Altice, James E. Egan, Patrick G. O'Connor, Lynn E. Sullivan, and David A. Fiellin. "Hepatic safety and lack of antiretroviral interactions with buprenorphine/naloxone in HIV-infected opioid-dependent patients." Journal of acquired immune deficiency syndromes (1999) 56 Suppl 1 (2011): S62-7. Abstract
2007
McCance-Katz, Elinore F., David E. Moody, Gene D. Morse, Qing Ma, Robin DiFrancesco, Gerald Friedland, Patricia Pade, and Petrie M. Rainey. "Interaction between buprenorphine and atazanavir or atazanavir/ritonavir." Drug and alcohol dependence 91, no. 2-3 (2007): 269-78. Abstract
2006
Bruce, Douglas R., and Frederick L. Altice. "Three case reports of a clinical pharmacokinetic interaction with buprenorphine and atazanavir plus ritonavir." AIDS (London, England) 20, no. 5 (2006): 783-4.
2005
Friedland, Gerald, Laurie Andrews, Tanya Schreibman, Sangeeta Agarwala, Leith Daley, Michael Child, Julia Shi, Yonghua Wang, and Edward O'Mara. "Lack of an effect of atazanavir on steady-state pharmacokinetics of methadone in patients chronically treated for opiate addiction." AIDS (London, England) 19, no. 15 (2005): 1635-41. Abstract